Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL5984544 | 0.81 | TSHR (0.39) | TSHRALDH1A1 | |
| Methacrylic Acid SCHEMBL9365250 | 0.78 | TP53 (0.36) | TSHRALDH1A1TDP1 | |
| Methacrylic Acid SCHEMBL27738548 | 0.78 | TDP1 (0.35) | TSHRALDH1A1TDP1 | |
| Methacrylic Acid SCHEMBL17453353 | 0.76 | SLC7A5 (0.40) | TSHRTDP1 | |
| Methacrylic Acid SCHEMBL867015 | 0.76 | TDP1 (0.33) | TSHRTDP1 | |
| Methacrylic Acid SCHEMBL3642985 | 0.75 | TSHR (0.39) | TSHRALDH1A1TDP1 | |
| Methacrylic Acid SCHEMBL28342863 | 0.74 | SLC7A5 (0.39) | TSHRTDP1 | |
| Methacrylic Acid SCHEMBL5841754 | 0.74 | TDP1 (0.44) | TSHRALDH1A1TDP1 | |
| Methacrylic Acid SCHEMBL2377019 | 0.74 | TDP1 (0.44) | TSHRALDH1A1TDP1 | |
| Methacrylic Acid SCHEMBL5843019 | 0.74 | TDP1 (0.44) | TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090041843-A1 | PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY | KOWA CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-1944029-A1 | PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY | Kowa Company, Ltd. (JP) | 2008-07-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090041843-A1 | PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY | HMGCR, PCSK9, CYP4A11 | TSHR 832/4885ALDH1A1 3431/4885TDP1 2557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.